Guided Therapeutics
4955 Avalon Ridge Parkway Suite 300
Norcross , GA 30071
USA
Product Categories:
Women's Health
Women's Health
RELATED CONTENT
News | Oncology Diagnostics
August 24, 2016 — Guided Therapeutics Inc. announced in late July that it has sold the first LuViva Advanced Cervical ...
August 24, 2016 
News | Oncology Diagnostics
Guided Therapeutics Inc. announced that Nairobi County Health Services Sector has agreed to purchase an additional five LuViva Advanced Cervical Scans for use in the agency’s cervical cancer screening program.
January 29, 2016 
News | Oncology Diagnostics
Guided Therapeutics Inc. announced that it has presented the U.S. Food and Drug Administration (FDA) with a plan for advancing the pre-market approval (PMA) application for the LuViva Advanced Cervical Scan. In its “pre-submission” letter, the company also requested a meeting with the agency to finalize the plan.
August 20, 2015 
News
Guided Therapeutics Inc. announced that U.S. Patent and Trademark Office granted a new patent with 22 claims that support the technology behind the LuViva Advanced Cervical Scan.
August 18, 2014 
News
Guided Therapeutics Inc. has filed an amendment to its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the LuViva Advanced Cervical Scan.
July 30, 2014 News
April 20, 2012 — Guided Therapeutics Inc. announced this week that the LuViva Advanced Cervical Scan is being introduced to medical leaders at the 40th Anniversary Meeting of the British Society for Colposcopy and Cervical Pathology (BSCCP) in Gateshead, United Kingdom, by Eurosurgical Ltd., the company’s U.K. distributor.
April 20, 2012 
News
January 3, 2011 — Guided Therapeutics Inc. announced that it was notified by the U.S. Food and Drug Administration (FDA) that the company’s premarket approval application (PMA) for the LightTouch cervical scanner, for patients at risk for cervical cancer, is “suitable for filing.”
January 03, 2011 
Technology
October 6, 2009 - The National Cancer Institute (NCI) awarded Guided Therapeutics, Inc. (GT) a $2.5 million matching grant to bring to market and expand the array features for its LightTouch non-invasive cervical cancer detection technology.
October 06, 2009 